Shares of Merck KGaA were losing around 3 percent in the morning trading after the German drug maker reported Thursday weak profit in its second quarter. Looking ahead, the company maintained fiscal 2018 forecast for organic sales growth and EBITDA pre.
from RTT - Earnings https://ift.tt/2nllgCy
via IFTTT
No comments:
Post a Comment